
==== Front
Eur J Nucl Med Mol Imaging
Eur J Nucl Med Mol Imaging
European Journal of Nuclear Medicine and Molecular Imaging
1619-7070
1619-7089
Springer Berlin Heidelberg Berlin/Heidelberg

38900309
6792
10.1007/s00259-024-06792-w
Correction
Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
Altunay Betül 1
Morgenroth Agnieszka 1
Beheshti Mohsen 123
Vogg Andreas 1
Wong Nicholas C. L. 4
Ting Hong Hoi 4
Biersack Hans-Jürgen 5
Stickeler Elmar 26
Mottaghy Felix M. fmottaghy@ukaachen.de

127
1 grid.412301.5 0000 0000 8653 1507 Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany
2 grid.1957.a 0000 0001 0728 696X Center of Integrated Oncology (CIO), Cologne and Düsseldorf, Universities of Aachen, Kerpener Str. 62, 50937 Bonn, Cologne, Germany
3 https://ror.org/03z3mg085 grid.21604.31 0000 0004 0523 5263 Division of Molecular PET-Imaging and Theranostics, Paracelsus Medical University, 5020 Salzburg, Austria
4 Nanomab Technology Limited, Shanghai, People’s Republic of China
5 https://ror.org/01xnwqx93 grid.15090.3d 0000 0000 8786 803X Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
6 https://ror.org/04xfq0f34 grid.1957.a 0000 0001 0728 696X Department of Gynecology and Obstetrics, RWTH Aachen, Aachen, Germany
7 https://ror.org/02jz4aj89 grid.5012.6 0000 0001 0481 6099 Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), 6202 Maastricht, The Netherlands
20 6 2024
20 6 2024
2024
51 11 34853485
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmc Correction to: European Journal of Nuclear Medicine and Molecular Imaging (2021) 48:1371–1389

10.1007/s00259-020-05094-1

The authors regret that there are some errors in the original published article. The below article note should be removed.

Betül Altunay and Agnieszka Morgenroth contributed equally to this work.

On the other hand, the “Authors’ contributions” section should be corrected from:

Conceptualization, writing—original draft preparation BA, AM; writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript.

to:

Conceptualization, writing—original draft preparation BA; writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript.

The original article has been corrected.

The online version of the original article can be found at 10.1007/s00259-020-05094-1

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
